| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/25/2006 | US7081471 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 07/25/2006 | US7081468 Angiogenesis inhibitors; antitumor agents; skin disorders; antiarthritic agents |
| 07/25/2006 | US7081467 C2-disubstituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 07/25/2006 | US7081460 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/25/2006 | US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone |
| 07/25/2006 | US7081261 Crystal structure, enzyme resistance, nonhydrolyzing, nonabsorption in the small intestine, and passes into the large intestine, fermentation by colonic microflora to maintain colonic health |
| 07/25/2006 | US7081260 α-Glucosidase inhibitors from a natural source |
| 07/25/2006 | US7081239 Administering formulation comprising peptide YY or antagonists of receptors for peptide YY for manipulating the rate of upper gastrointestinal transit of a substance in a mammal having an intrinsic cholinergic afferent neural pathway |
| 07/25/2006 | CA2369095C Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
| 07/25/2006 | CA2289209C Cyclic ether vitamin d3 compounds, 1.alpha. (oh) 3-epi-vitamin d3 compounds and uses thereof |
| 07/25/2006 | CA2235430C Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof |
| 07/20/2006 | WO2006076598A2 Bicyclic heterocycles as cannabinoid receptor modulators |
| 07/20/2006 | WO2006076595A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 07/20/2006 | WO2006076494A1 Catalpic acid for the treatment of type 2 diabetes and associated disorders |
| 07/20/2006 | WO2006076317A2 Aminophenyl derivatives as selective androgen receptor modulators |
| 07/20/2006 | WO2006076240A2 Compositions, products and methods for controlling weight in a mammal |
| 07/20/2006 | WO2006076231A2 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 07/20/2006 | WO2006075976A1 Application of a local anaesthetic for correcting a human eating behaviour and method for the use thereof |
| 07/20/2006 | WO2006075642A1 Hypoxia response enhancing agent |
| 07/20/2006 | WO2006075638A1 Novel heteroaryl derivative |
| 07/20/2006 | WO2006075523A1 Blood cholesterol reducing oral composition |
| 07/20/2006 | WO2006075502A1 Solid preparation comprising reduced coenzyme q10 and process for production of the same |
| 07/20/2006 | WO2006075476A1 Functional fermented turmeric food material and process for producing the same |
| 07/20/2006 | WO2006075023A2 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/20/2006 | WO2006074957A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments |
| 07/20/2006 | WO2006074789A1 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists |
| 07/20/2006 | WO2006074600A1 Modified exendins and uses thereof |
| 07/20/2006 | WO2006059210A3 Fused bicyclic pyrrols as hmg-coa reductase inhibitors |
| 07/20/2006 | WO2006054057A3 New use for cannabinoid |
| 07/20/2006 | WO2006044531A3 Antisense modulation of ptp1b expression |
| 07/20/2006 | WO2006044174A9 Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor |
| 07/20/2006 | WO2006043966A3 Methods for inducing apoptosis in adipocytes |
| 07/20/2006 | WO2006036871A3 Plant pr-5 proteins as mammalian therapeutic agents |
| 07/20/2006 | WO2006012499A3 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| 07/20/2006 | WO2005120487A3 Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders |
| 07/20/2006 | WO2003101177A3 Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions |
| 07/20/2006 | US20060161018 Amino acid composition |
| 07/20/2006 | US20060160851 Substituted piperidine carbamates |
| 07/20/2006 | US20060160848 Method of controlling damage mediated by alpha, beta-unsaturated aldehydes |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160820 Substituted piperazine carbamates |
| 07/20/2006 | US20060160819 Substitued piperazine carbamates |
| 07/20/2006 | US20060160816 Pirazino(AZA) indole derivatives |
| 07/20/2006 | US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/20/2006 | US20060160796 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases |
| 07/20/2006 | US20060160768 Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 07/20/2006 | US20060160767 Method of providing food product with prolonged energy release |
| 07/20/2006 | US20060160723 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 07/20/2006 | US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/20/2006 | US20060160142 Phosophoinositoglycan binding proteins |
| 07/20/2006 | US20060159779 treating Type II diabetes by administering a foodstuff or beverage containing a dried extract of a plant of the genus Hoodia; trigyleride; 3-0-[-.beta.-D-thevetopyranosyl-(1-4)-.beta.-D-cymaropyranosyl-(1-4)-.beta.-D-cymaropyranosyl]-12.beta.-0-tigloyloxy-14-hydroxy-14.beta.-pregn-50-ene-20-one |
| 07/20/2006 | US20060159770 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 07/20/2006 | US20060159759 Tablet containing water-absorbing amino acid |
| 07/20/2006 | US20060159749 Mesalamine inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices |
| 07/20/2006 | DE102005001479A1 Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung Compositions comprising folic acid, vitamin B6 and vitamin B12, and its use |
| 07/20/2006 | DE102005001053A1 Quadratsäurederivate Squaric acid derivatives |
| 07/20/2006 | CA2603630A1 Modified exendins and uses thereof |
| 07/20/2006 | CA2601343A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments |
| 07/20/2006 | CA2594377A1 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists |
| 07/20/2006 | CA2594340A1 Aminophenyl derivatives as selective androgen receptor modulators |
| 07/20/2006 | CA2592457A1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 07/20/2006 | CA2588925A1 Solid preparation comprising reduced coenzyme q10 and process for production of the same |
| 07/19/2006 | EP1681355A1 Sequence-specific DNA recombination in eukaryotic cells |
| 07/19/2006 | EP1681305A2 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 07/19/2006 | EP1681296A1 Epimeredi glycoside a, the formulation containing thereof and their preparation method |
| 07/19/2006 | EP1681057A1 Use of naloxone for treating eating disorders |
| 07/19/2006 | EP1680963A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/19/2006 | EP1680413A1 New rar$g(b) receptor-activating ligand, method for the preparation thereof and use thereof in human medicine and in cosmetics |
| 07/19/2006 | EP1680140A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 07/19/2006 | EP1680117A2 Use of a pyrazole derivative for preparing medicaments for the prevention and the treatment of dyslipidemia and illnesses associated with dyslipidemia and/or obesity |
| 07/19/2006 | EP1680112A2 Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof |
| 07/19/2006 | EP1444215B1 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 07/19/2006 | EP1399142B1 Use of acetyl l-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus |
| 07/19/2006 | EP1389137B1 Compositions for protein delivery via the pulmonary route |
| 07/19/2006 | EP1379695B1 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 07/19/2006 | EP1301507B1 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 07/19/2006 | EP1268453B1 Estrogen agonist/antagonist metabolites |
| 07/19/2006 | EP1263740B1 Pyrimidine-4-one derivative as ldl-pla2 inhibitor |
| 07/19/2006 | EP1230920B1 Use of food materials in preventing and ameliorating metabolic bone diseases |
| 07/19/2006 | EP1194146B1 Arylthiazolidinedione and aryloxazolidinedione derivatives |
| 07/19/2006 | CN1805951A Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase |
| 07/19/2006 | CN1805934A 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl)piperidine as glucosylceramide synthase (GCS) inhibitor |
| 07/19/2006 | CN1805933A 2-hydroxymethyl-3,4,5-trihydroxy-1benzylpiperidine derivatives as inhibitors of glucosylceramide synthase (gcs) |
| 07/19/2006 | CN1805922A Pharmaceutically useful salts of carboxylic acid derivates |
| 07/19/2006 | CN1805745A 2-aminobenzothiazoles as CB1 receptor inverse agonists |
| 07/19/2006 | CN1805738A Extended-release tablets of metformin |
| 07/19/2006 | CN1803830A Artificial synthesized insulin-simulated peptide and its application |
| 07/19/2006 | CN1803797A Inhibitors of dipeptidyl peptidase IV |
| 07/19/2006 | CN1803795A Substituted piperidine compounds for use as h3 histamine receptor antagonists |
| 07/19/2006 | CN1803181A Pharmaceutical soft capsule for treating hyperlipemia and its preparation method |
| 07/19/2006 | CN1803165A Burdock microecological formulation |
| 07/19/2006 | CN1803160A Fat-reducing article |
| 07/19/2006 | CN1803014A Instant pilose antler |
| 07/19/2006 | CN1802976A Canton love-pea vine healthcare tea and its preparation method |
| 07/19/2006 | CN1802968A Chinese medicinal healthcare tea and its preparation method |
| 07/19/2006 | CN1264978C Alpha-amylase activity inhibitors |
| 07/19/2006 | CN1264858C Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 07/19/2006 | CN1264846C Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 07/19/2006 | CN1264561C Combination of medication for curing hyperlipemia, arteriosclerosis, coronary heart disease and fatty liver |